147 related articles for article (PubMed ID: 16837162)
1. Selective cyclooxygenase inhibition: its role in pain and anaesthesia.
Langford RM; Mehta V
Biomed Pharmacother; 2006 Aug; 60(7):323-8. PubMed ID: 16837162
[TBL] [Abstract][Full Text] [Related]
2. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.
Vuolteenaho K; Moilanen T; Moilanen E
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):10-4. PubMed ID: 17973900
[TBL] [Abstract][Full Text] [Related]
3. [Is there a future for COX-2 inhibitors?].
Yodfat Y
Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
Dajani EZ; Islam K
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
[TBL] [Abstract][Full Text] [Related]
5. Coxibs: Evolving role in pain management.
Katz N
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):15-24. PubMed ID: 12528070
[TBL] [Abstract][Full Text] [Related]
6. One hundred years of NSAID gastropathy: are coxibs the answer?
Bjorkman DJ
Rev Gastroenterol Disord; 2001; 1(3):121-7. PubMed ID: 12120179
[TBL] [Abstract][Full Text] [Related]
7. Coxibs: is there a benefit when compared to traditional non-selective NSAIDs in postoperative pain management?
Wickerts L; Warrén Stomberg M; Brattwall M; Jakobsson J
Minerva Anestesiol; 2011 Nov; 77(11):1084-98. PubMed ID: 21617597
[TBL] [Abstract][Full Text] [Related]
8. Update on the role of nonsteroidal anti-inflammatory drugs and coxibs in the management of acute pain.
Reuben SS
Curr Opin Anaesthesiol; 2007 Oct; 20(5):440-50. PubMed ID: 17873597
[TBL] [Abstract][Full Text] [Related]
9. COX-2 inhibitors: pharmacological data and adverse effects.
Mattia C; Coluzzi F
Minerva Anestesiol; 2005; 71(7-8):461-70. PubMed ID: 16012420
[TBL] [Abstract][Full Text] [Related]
10. [Analgesic effects of cyclooxygenase 2 inhibitors].
Jayr C
Bull Cancer; 2004 May; 91 Spec No():S125-31. PubMed ID: 15239341
[TBL] [Abstract][Full Text] [Related]
11. Choosing nonselective NSAIDs and selective COX-2 inhibitors in the elderly. A clinical use pathway.
Stillman MJ; Stillman MT
Geriatrics; 2007 Feb; 62(2):26-34. PubMed ID: 17291140
[TBL] [Abstract][Full Text] [Related]
12. COX-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery.
Cicconetti A; Bartoli A; Ripari F; Ripari A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):139-46. PubMed ID: 14970772
[TBL] [Abstract][Full Text] [Related]
13. Selective cyclooxygenase inhibition in pain management.
Pertusi RM
J Am Osteopath Assoc; 2004 Nov; 104(11 Suppl 8):S19-24. PubMed ID: 15602037
[TBL] [Abstract][Full Text] [Related]
14. Current and emerging treatments for mild/moderate acute ambulatory pain.
Weaver AL
Am J Ther; 2008; 15 Suppl 10():S12-6. PubMed ID: 19127123
[TBL] [Abstract][Full Text] [Related]
15. Making progress in the management of postoperative pain: a review of the cyclooxygenase 2-specific inhibitors.
Stephens JM; Pashos CL; Haider S; Wong JM
Pharmacotherapy; 2004 Dec; 24(12):1714-31. PubMed ID: 15585440
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal gastropathy in dentistry--issues and controversies in patient's management.
Afolabi AO; Adekanle OA
Niger J Med; 2009; 18(1):39-42. PubMed ID: 19485146
[TBL] [Abstract][Full Text] [Related]
17. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
[TBL] [Abstract][Full Text] [Related]
18. [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain].
Bijlsma JW; Lems WF; van de Laar MA
Ned Tijdschr Geneeskd; 2007 Apr; 151(14):795-8. PubMed ID: 17469317
[TBL] [Abstract][Full Text] [Related]
19. Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.
Hinz B; Renner B; Brune K
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):552-60; quiz 1 p following 589. PubMed ID: 17906610
[TBL] [Abstract][Full Text] [Related]
20. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies.
Lanas A; Hunt R
Ann Med; 2006; 38(6):415-28. PubMed ID: 17008305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
